American Association for the Study of Liver Diseases and the International Liver Transplantation Society Course, Part 2: Substance Use Disorders (Ticketed)
Nov
08
2025
Convention Center: Room 145, Level 1
9:45 AM - 10:45 AM
Ticketed Event
Description
Delve into the complexities of liver transplantation among patients with alcohol-associated liver disease (ALD). Topics include the clinical and logistical resources required, ethical considerations—especially in living donor contexts—and the critical role of relapse prevention and psychosocial support in long-term outcomes.Journey Maps
Presentations
9:45 AM - 9:55 AM
Nov
08
2025
San Diego, CA
Alcohol-Associated Hepatitis: Is It Time to Standardize Patient Selection?
Vijay H. Shah, MD, FAASLD, Presenter
Transplant
9:55 AM - 10:05 AM
Nov
08
2025
San Diego, CA
Resource Utilization for Transplantation of Patients With Alcohol-Associated Hepatitis
Nazia Selzner, MD, PhD, Presenter
Transplant
10:05 AM - 10:15 AM
Nov
08
2025
San Diego, CA
Preventing Alcohol Relapse: Before and After Transplant
Norah Terrault, MD, MPH, FAASLD, Presenter
Transplant
10:15 AM - 10:25 AM
Nov
08
2025
San Diego, CA
Ethical Considerations for Transplanting a Patient With Alcohol-Associated Liver Disease Including Living Donor Inequities
Ramesh C Batra, MD, MA(Bioethics), FRCS, Presenter
Transplant
10:25 AM - 10:45 AM
Nov
08
2025
San Diego, CA
Q&A
Raiya Sarwar, MD, Moderator
Transplant
Objectives
- Discuss current insights into the management of alcohol use and liver transplantation.
- List resources required for transplantation and management of patients with alcohol-associated liver disease (ALD).
- Review ethical issues regarding liver transplantation of patients with ALD, particularly with a living donor.
- Explain the requirement and necessity of relapse prevention treatment in patients with ALD.
Chair
Ramesh C Batra, MD, MA(Bioethics), FRCS
Chair
Ryutaro P Hirose, MD
University of Washington Medical Center